SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients
Clinical trial NCT04154956 · TERMINATED
Trial details
- NCT number
- NCT04154956
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-06
- Primary completion
- 2023-09-22
- Enrollment
- 389
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.